Trial Profile
Phase 2 treatment of adults with primary malignant glioma with karenitecin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 May 2021
Price :
$35
*
At a glance
- Drugs Cositecan (Primary)
- Indications Anaplastic astrocytoma; CNS cancer; Glioblastoma; Glioma; Oligodendroglioma
- Focus Therapeutic Use
- Sponsors BioNumerik Pharmaceuticals
- 11 May 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 22 Sep 2005 New trial record.